PURPOSE: We assessed factors associated with mortality and complicated course in the case of Clostridium difficile infection (CDI) acquired in the intensive care unit (ICU). METHOD: Retrospective cohort study conducted from 1 January 2002 through 1 January 2012. All patients who acquired CDI in our ICU were included. RESULTS: Thirty-one patients were included. Twenty patients (65 %) had mild colitis, 8 (25 %) moderate colitis, and 3 (10 %) severe colitis. Initial antibiotherapy was metronidazole (n = 30, 97 %) and vancomycin (n = 1, 3 %). Seventeen patients (55 %) experienced at least one complication: failure of initial treatment (n = 16, 52 %), shock (n = 11, 34 %), need for surgery (n = 1, 3 %) or renal replacement (n = 4, 13 %), or death (n = 8, 26 %). Risk factors of ICU mortality were history of corticosteroids prescription, prolonged ICU stay, low serum albumin level, and high Sequential Organ Failure Assessment (SOFA) score at the time of CDI diagnosis. Factors associated with a complicated course were high Simplified Acute Physiology Score (SAPS II), high SOFA score, and low serum albumin level at the time of CDI onset. CONCLUSION: Risk factors of poor outcome in patients with CDI acquired in the ICU are different from those in the general population suffering from CDI. The implementation of treatment algorithms taking into account these factors may reduce complication rates in this specific population.
PURPOSE: We assessed factors associated with mortality and complicated course in the case of Clostridium difficile infection (CDI) acquired in the intensive care unit (ICU). METHOD: Retrospective cohort study conducted from 1 January 2002 through 1 January 2012. All patients who acquired CDI in our ICU were included. RESULTS: Thirty-one patients were included. Twenty patients (65 %) had mild colitis, 8 (25 %) moderate colitis, and 3 (10 %) severe colitis. Initial antibiotherapy was metronidazole (n = 30, 97 %) and vancomycin (n = 1, 3 %). Seventeen patients (55 %) experienced at least one complication: failure of initial treatment (n = 16, 52 %), shock (n = 11, 34 %), need for surgery (n = 1, 3 %) or renal replacement (n = 4, 13 %), or death (n = 8, 26 %). Risk factors of ICU mortality were history of corticosteroids prescription, prolonged ICU stay, low serum albumin level, and high Sequential Organ Failure Assessment (SOFA) score at the time of CDI diagnosis. Factors associated with a complicated course were high Simplified Acute Physiology Score (SAPS II), high SOFA score, and low serum albumin level at the time of CDI onset. CONCLUSION: Risk factors of poor outcome in patients with CDI acquired in the ICU are different from those in the general population suffering from CDI. The implementation of treatment algorithms taking into account these factors may reduce complication rates in this specific population.
Authors: Scott T Micek; Nareg Roubinian; Tim Heuring; Meghan Bode; Jennifer Williams; Courtney Harrison; Theresa Murphy; Donna Prentice; Brent E Ruoff; Marin H Kollef Journal: Crit Care Med Date: 2006-11 Impact factor: 7.598
Authors: F Barbut; G Corthier; Y Charpak; M Cerf; H Monteil; T Fosse; A Trévoux; B De Barbeyrac; Y Boussougant; S Tigaud; F Tytgat; A Sédallian; S Duborgel; A Collignon; M E Le Guern; P Bernasconi; J C Petit Journal: Arch Intern Med Date: 1996-07-08
Authors: Saif A Musa; Carl Moran; Sam J Thomson; Matthew L Cowan; Greg McAnulty; Michael Grounds; Tony Manibur Rahman Journal: J Cardiothorac Vasc Anesth Date: 2011-04 Impact factor: 2.628
Authors: Naomi P O'Grady; Philip S Barie; John G Bartlett; Thomas Bleck; Karen Carroll; Andre C Kalil; Peter Linden; Dennis G Maki; David Nierman; William Pasculle; Henry Masur Journal: Crit Care Med Date: 2008-04 Impact factor: 7.598
Authors: S M Heimann; J J Vehreschild; O A Cornely; H Wisplinghoff; M Hallek; R Goldbrunner; B W Böttiger; T Goeser; A Hölscher; S Baldus; F Müller; N Jazmati; S Wingen; B Franke; M J G T Vehreschild Journal: Infection Date: 2015-06-30 Impact factor: 3.553
Authors: Styliani Karanika; Suresh Paudel; Fainareti N Zervou; Christos Grigoras; Ioannis M Zacharioudakis; Eleftherios Mylonakis Journal: Open Forum Infect Dis Date: 2015-12-01 Impact factor: 3.835
Authors: Małgorzata Salamonowicz; T Ociepa; J Frączkiewicz; A Szmydki-Baran; M Matysiak; K Czyżewski; M Wysocki; P Gałązka; P Zalas-Więcek; N Irga-Jaworska; E Drożyńska; O Zając-Spychała; J Wachowiak; O Gryniewicz-Kwiatkowska; A Czajńska-Deptuła; B Dembowska-Bagińska; L Chełmecka-Wiktorczyk; W Balwierz; M Bartnik; K Zielezińska; T Urasiński; R Tomaszewska; T Szczepański; M Płonowski; M Krawczuk-Rybak; F Pierlejewski; W Młynarski; Z Gamrot-Pyka; M Woszczyk; Z Małas; W Badowska; A Urbanek-Dądela; G Karolczyk; W Stolpa; G Sobol-Milejska; A Zaucha-Prażmo; J Kowalczyk; J Goździk; E Gorczyńska; K Jermakow; A Król; A Chybicka; M Ussowicz; K Kałwak; J Styczyński Journal: Eur J Clin Microbiol Infect Dis Date: 2018-07-05 Impact factor: 3.267